Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Endocrine, Metabolic & Immune Disorders Drug Targets|April 12, 2011
A pharmacological primer of biased agonismBradley T AndresenMethods in Enzymology|November 2, 2010
Characterization of G protein-coupled receptor kinase 4 and measuring its constitutive activity in vivoBradley T AndresenWorld Journal of Cardiology|December 31, 2010
Inflammation and reactive oxygen species in cardiovascular diseaseNannan Zhang, Bradley T Andresen, Cuihua ZhangBiologics : Targets & Therapy|August 27, 2009
Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide actionLina Nordquist, Fredrik Palm, Bradley T AndresenThe Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cellsBradley T Andresen, Guillermo G Romero, Edwin K JacksonJID Innovations : Skin Science From Molecules to Population Health|April 24, 2025
Carvedilol Prevents UV-Induced Immunosuppression and Skin Carcinogenesis through a Mechanism Independent of β-BlockadeAyaz Shahid, Fanglong Dong, Bradley T Andresen, et al.Advances in Pharmacology (San Diego, Calif.)|June 6, 2022
Polymorphisms in common antihypertensive targets: Pharmacogenomic implications for the treatment of cardiovascular diseaseDominique Brown, Heather Alcala, Peter Oelschlaeger, et al.Biochemical and Biophysical Research Communications|January 15, 2008
G protein-coupled receptor kinase 4gamma interacts with inactive Galpha(s) and Galpha13Lindsay B Keever, John E Jones, Bradley T AndresenThoracic Cancer|June 19, 2025
S- and R-Carvedilol Prevent Benzo(a)pyrene-Induced Lung CarcinogenesisAyaz Shahid, Steven Yeung, Bradley T Andresen, et al.FEBS Letters|October 29, 2002
The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascadeBradley T Andresen, Mark A Rizzo, Kuntala Shome, et al.Pageof 4